Next Science Limited

ASX (AUD): Next Science Limited (NXS)

Last Price

0.135

Today's Change

-0.007 (4.92%)

Day's Change

0.135 - 0.14

Trading Volume

10,699

Profile
NXS

Exchange:  Australian Securities Exchange Australian Securities Exchange

Currency:  AUD AUD

Sector:  Healthcare - Healthcare Healthcare - Healthcare

Industry: 

CEO:  Mr. Harry Thomas Hall Mr. Harry Thomas Hall

Full Time Employees:  0 0

IPO Date:  2019-04-18 2019-04-18

CIK: 

ISIN:  AU0000041329 AU0000041329

CUSIP:  Q67516106 Q67516106

Beta:  1.51 1.51

Last Dividend:  0.00 0.00

Dcf Diff:  0.00 0.00

Dcf:  0.00 0.00

Description

Next Science Limited, a medical technology company, researches, develops, and commercializes technologies that address the impacts of biofilms in human health in the United States and Australia. The company develops its products using Xbio Technology platform. It offers SURGX, an antimicrobial gel designed for surgical infection management; BACTISURE, a wound lavage that is used to remove biofilm; BlastX, an antimicrobial wound gel that destroys bacteria within the gel and defends from recolonization while maintaining a moist wound environment; and XPERIENCE, an no rinse antimicrobial solution that helps prevent surgical site infections. Next Science Limited was founded in 2012 and is headquartered in Chatswood, Australia.

Address

The Zenith Building, Tower A,
Chatswood, NSW 2067, AU

61 2 8607 5126

http://www.nextscience.com

Discussions
Be the first to like this. Showing 0 of 0 comments

Post a Comment